Herbs Generation Group Holdings Limited Class H
HHKEX:25931.05
HKD
+0.04
(+3.98%)
Herbs Generation Group Holdings Limited Class H
HKEX:2593
(Hong Kong Exchange)
Recent
price
1.05
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
HKD
•
in mil. unless spec.Working Capital
HKD
•
in mil. unless spec.Growth Rates
HKD
•
in mil. unless spec.Semi-annual Revenue
HKD
•
in mil. unless spec.Semi-annual Earnings Per Share
HKD
•
in mil. unless spec.Semi-annual Dividends Per Share
HKD
•
in mil. unless spec.- Similar Companies
- Business
- Herbs Generation Group Holdings Limited is a Hong Kong-based provider of health supplements, cosmetics, skincare products, and pet health supplements, focusing on the development, marketing, and sale of own-brand products through multi-channel distribution including retail shops, wholesale to chain and non-chain retailers, consignment arrangements, and e-commerce platforms such as Zinomall, HKTVmall, and Tmall.hk. Founded in 1999 and headquartered at Units A7-A8, 6/F, NCB Innovation Centre, 888 Lai Chi Kok Road, Kowloon, Hong Kong, the company operates primarily in the household and personal care products sector, targeting consumers in Hong Kong with offerings under nine brands: Herbs (草姬), ZINO, Classic (正統), Umeya (梅屋), Energie (男補), Men’s INFiNiTY (男極), Regal Green (綠康營), Herbs Pet (恩寵), and MedHerbs; its health supplements address cardiovascular health, immunity boosting, metabolic syndrome management including three highs, liver and kidney support, brain function, midlife care, men's and women's health, eye care, bones and joints, hair growth, insomnia relief, detoxification, weight management, and allergy care, while cosmetics and skincare products include serums, creams, masks, makeup removers, feminine care, and facial cleansers, and pet supplements cater to animal wellness. As a subsidiary of Joy & Love Limited, the group listed on the Main Board of The Stock Exchange of Hong Kong (ticker: 2593.HK) in December 2024 via an initial public offering that raised net proceeds of approximately HK$94.4 million for strategic marketing, sales network expansion from 23 to 33 self-operated retail shops, product diversification, talent recruitment, and working capital; recent developments include the launch of new products such as Herbs Tiger Pro Lung Health (草姬虎乳芝咳喘消) for respiratory support and the MedHerbs brand in the first half of 2025, alongside a head office relocation, intensified advertising with KOLs and entertainers amid a 3.3% decline in Hong Kong retail sales, right-of-use asset additions of HK$3.6 million for new leases, and planned further innovation and capital expenditures funded by operations and IPO proceeds despite recording a HK$7.5 million net loss for the six months ended 30 June 2025 due to higher promotional sales, staff costs, and distribution expenses.